Introduction: The brain-derived neurotrophic factor (BDNF) and transcription nuclear factor erythroid 2-related factor-2 (NRF-2) play an important role in Alzheimer’s disease (AD). However, the interactive involvement of BDNF and NRF-2 in respect to antioxidant mechanisms in different parts of the AD brain is still unclear. Considering the above condition, used S-nitrosoglutathione (GSNO) to examine whether it modulates the BDNF and NRF-2 levels to activate signaling pathway to promote antioxidant levels in AD brains. Method: AD was induced by intracerebroventricular infusion of streptozotocin (ICV-STZ, 3 mg/kg) in Wistar rats. The effect of GSNO was analyzed by evaluating the retention of memory in months 1, 2, and 3. After the behavior study, rats were sacrificed and accessed the amyloid beta (Aβ)-40, Aβ42, glutathione (GSH), BDNF, and NRF-2 levels in the hippocampus, cortex, and amygdala tissue. Results: Pretreatment with GSNO (50 µg/kg/intraperitoneal/day) restored the BDNF, and NRF-2 levels toward normalcy as compared with ICV-STZ + saline-treated animals. Also, GSNO treatment reversed the oxidative stress and increased the GSH levels toward normal levels. Further, reduced Aβ levels and neuronal loss in different brain regions. As a result, GSNO treatment improved the cognitive deficits in ICV-STZ-treated rats. Conclusion: The results showed that endogenous nitric oxide donor GSNO improved the cognitive deficits and ICV-STZ-induced AD pathological conditions, possibly via attenuating the oxidative stress. Hence, the above finding supported that GSNO treatment may activate BDNF and NRF-2 antioxidant signaling pathways in the AD brain to normalize oxidative stress, which is the main causative factor for ICV-STZ-induced AD pathogenesis.

This work is mainly focused on the investigation of the antioxidant activity of S-nitrosoglutathione (GSNO) in intracerebroventricular infusion of streptozotocin (ICV-STZ)-induced Alzheimer’s disease (AD) in rats. GSNO is an endogenous nitric oxide donor and has potent antioxidant activities. Our study revealed for the first time that GSNO may have antioxidant activities in AD by improving the endogenous antioxidant defense system. Further, GSNO treatment improved spatial retention and contextual fear memory in rats. Also, GSNO treatment decreased the AD neuropathological parameters (neuronal damage, amyloid beta-Aβ40, Aβ42) and improved the neuroprotective parameters (GSH, brain-derived neurotrophic factor, and nuclear factor erythroid 2-related factor-2) levels in AD brain tissues. These findings indicate that GSNO activates the neuronal antioxidant defense system and normalizes oxidative stress in the AD brain.

1.
Dementia [internet]
. [cited 2023 Mar 31]. Available from: https://www.who.int/news-room/fact-sheets/detail/dementia.
2.
Wiley
.
2023 Alzheimer’s disease facts and figures
.
Alzheimers Dement
.
2023
;
19
(
4
):
1598
695
.
3.
Dubey
H
,
Gulati
K
,
Ray
A
.
Recent studies on cellular and molecular mechanisms in Alzheimer’s disease: focus on epigenetic factors and histone deacetylase
.
Rev Neurosci
.
2018
;
29
(
3
):
241
60
.
4.
Dubey
H
,
Gulati
K
,
Ray
A
.
Amelioration by nitric oxide (NO) mimetics on neurobehavioral and biochemical changes in experimental model of Alzheimer’s disease in rats
.
Neurotoxicology
.
2018
;
66
:
58
65
.
5.
Murphy
KE
,
Park
JJ
.
Can co-activation of Nrf2 and neurotrophic signaling pathway slow Alzheimer’s disease
.
Int J Mol Sci
.
2017
;
18
(
6
):
1168
.
6.
Gan
L
,
Johnson
JA
.
Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases
.
Biochim Biophys Acta
.
2014
;
1842
(
8
):
1208
18
.
7.
Lu
MC
,
Ji
JA
,
Jiang
YL
,
Chen
ZY
,
Yuan
ZW
,
You
QD
, et al
.
An inhibitor of the Keap1-Nrf2 protein-protein interaction protects NCM460 colonic cells and alleviates experimental colitis
.
Sci Rep
.
2016
;
6
:
26585
.
8.
Harvey
CJ
,
Thimmulappa
RK
,
Singh
A
,
Blake
DJ
,
Ling
G
,
Wakabayashi
N
, et al
.
Nrf2-regulated glutathione recycling independent of biosynthesis is critical for cell survival during oxidative stress
.
Free Radic Biol Med
.
2009
;
46
(
4
):
443
53
.
9.
Gella
A
,
Durany
N
.
Oxidative stress in Alzheimer disease
.
Cell Adh Migr
.
2009
;
3
(
1
):
88
93
.
10.
Dubey
H
,
Gulati
K
,
Ray
A
.
Journal of pharmacological reports effects of nitric oxide ( NO ) modulators on cognitive function and brain oxidative stress in experimental model of alzheimer’s disease in rats
.
2017
;
2
(
2
).
11.
Yao
W
,
Zhang
JC
,
Ishima
T
,
Dong
C
,
Yang
C
,
Ren
Q
, et al
.
Role of Keap1-Nrf2 signaling in depression and dietary intake of glucoraphanin confers stress resilience in mice
.
Sci Rep
.
2016
;
6
:
30659
.
12.
Nagahara
AH
,
Merrill
DA
,
Coppola
G
,
Tsukada
S
,
Schroeder
BE
,
Shaked
GM
, et al
.
Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer’s disease
.
Nat Med
.
2009
;
15
(
3
):
331
7
.
13.
Zhang
T
,
Pan
B
,
Zhao
B
,
Zhang
L
,
Huang
YL
,
Sun
FY
.
Exacerbation of poststroke dementia by type 2 diabetes IS associated with synergIStic increases of -secretase activation and -amyloid generation in rat brains
.
NSC
.
2009
;
161
(
4
):
1045
56
.
14.
Wang
J
,
Zhao
X
,
He
M
.
Is BDNF biological link between depression and type 2 diabetes mellitus
.
Med Hypotheses
.
2012
;
79
(
2
):
255
8
.
15.
Xu
P
,
Wang
K
,
Lu
C
,
Dong
L
,
Gao
L
,
Yan
M
, et al
.
The protective effect of lavender essential oil and its main component linalool against the cognitive deficits induced by D-galactose and aluminum trichloride in mice
.
Evid Based Complement Alternat Med
.
2017
;
2017
:
7426538
.
16.
Paul
V
,
Ekambaram
P
.
Involvement of nitric oxide in learning & memory processes
.
Indian J Med Res
.
2011
;
133
(
5
):
471
8
.
17.
Huang
CC
,
Lin
TJ
,
Lu
YF
,
Chen
CC
,
Huang
CY
,
Lin
WT
.
Protective effects of L-arginine supplementation against exhaustive exercise-induced oxidative stress in young rat tissues
.
Chin J Physiol
.
2009
;
52
(
5
):
306
15
.
18.
Biojone
C
,
Casarotto
P
,
Joca
S
,
Castren
E
.
Interplay between nitric oxide and brain-derived neurotrophic factor in neuronal plasticity
.
CNS Neurol Disord Drug Targets
.
2015
;
14
(
8
):
979
87
.
19.
Tian
N
,
Cao
Z
,
Zhang
Y
.
MiR-206 decreases brain-derived neurotrophic factor levels in a transgenic mouse model of Alzheimer’s disease
.
Neurosci Bull
.
2014
;
30
(
2
):
191
7
.
20.
Um
HC
,
Jang
JH
,
Kim
DH
,
Lee
C
,
Surh
YJ
.
Nitric oxide activates Nrf2 through S-nitrosylation of Keap1 in PC12 cells
.
Nitric Oxide
.
2011
;
25
(
2
):
161
8
.
21.
Calabrese
V
,
Mancuso
C
,
Calvani
M
,
Rizzarelli
E
,
Butterfield
DA
,
Stella
AMG
.
Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity
.
Nat Rev Neurosci
.
2007
;
8
(
10
):
766
75
.
22.
Rosas-Vidal
LE
,
Do-Monte
FH
,
Sotres-Bayon
F
,
Quirk
GJ
.
Hippocampal-prefrontal BDNF and memory for fear extinction
.
Neuropsychopharmacology
.
2014
;
39
(
9
):
2161
9
.
23.
Heldt
SA
,
Stanek
L
,
Chhatwal
JP
,
Ressler
KJ
.
Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories
.
Mol Psychiatry
.
2007
;
12
(
7
):
656
70
.
24.
Herry
C
,
Ferraguti
F
,
Singewald
N
,
Letzkus
JJ
,
Ehrlich
I
,
Lüthi
A
.
Neuronal circuits of fear extinction
.
Eur J Neurosci
.
2010
;
31
(
4
):
599
612
.
25.
Lonsdorf
TB
,
Haaker
J
,
Kalisch
R
.
Long-term expression of human contextual fear and extinction memories involves amygdala, hippocampus and ventromedial prefrontal cortex: a reinstatement study in two independent samples
.
Soc Cogn Affect Neurosci
.
2014
;
9
(
12
):
1973
83
.
26.
Huff
NC
,
Rudy
JW
.
The amygdala modulates hippocampus-dependent context memory formation and stores cue-shock associations
.
Behav Neurosci
.
2004
;
118
(
1
):
53
62
.
27.
Broniowska
KA
,
Diers
AR
,
Hogg
N
.
S-Nitrosoglutathione
.
Biochim Biophys Acta
.
2013
;
1830
(
5
):
3173
81
.
28.
Khan
M
,
Sakakima
H
,
Dhammu
TS
,
Shunmugavel
A
,
Im
Y-B
,
Gilg
AG
, et al
.
S-Nitrosoglutathione reduces oxidative injury and promotes mechanisms of neurorepair following traumatic brain injury in rats
.
J Neuroinflammation
.
2011
;
8
(
1
):
78
.
29.
Paxinos
G
,
Watson
C
.
The rat brain in stereotaxic coordinates
. 7th ed.
Elsevier Academic Press
;
2014
; p.
170
.
30.
Ozkay
UD
,
Can
OD
,
Ozkay
Y
,
Oztürk
Y
.
Effect of benzothiazole/piperazine derivatives on intracerebroventricular streptozotocin-induced cognitive deficits
.
Pharmacol Rep
.
2012
;
64
(
4
):
834
47
.
31.
Ishrat
T
,
Parveen
K
,
Khan
MM
,
Khuwaja
G
,
Khan
MB
,
Yousuf
S
, et al
.
Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer’s type
.
Brain Res
.
2009
;
1281
:
117
27
.
32.
Tiwari
S
,
Singh
S
.
Reciprocal upshot of nitric oxide, endoplasmic reticulum stress, and ubiquitin proteasome system in Parkinson’s disease pathology
.
Neuroscientist
.
2021
;
27
(
4
):
340
54
.
33.
Wang
H
,
Wang
H
,
Cheng
H
,
Che
Z
.
Ameliorating effect of luteolin on memory impairment in an Alzheimer’s disease model
.
Mol Med Rep
.
2016
;
13
(
5
):
4215
20
.
34.
Won
J-S
,
Kim
J
,
Annamalai
B
,
Shunmugavel
A
,
Singh
I
,
Singh
AK
.
Protective role of S-nitrosoglutathione (GSNO) against cognitive impairment in rat model of chronic cerebral hypoperfusion
.
J Alzheimers Dis
.
2013
;
34
(
3
):
621
35
.
35.
Salkovic-Petrisic
M
,
Knezovic
A
,
Hoyer
S
,
Riederer
P
.
What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer’s disease, about the therapeutic strategies in Alzheimer’s research
.
J Neural Transm
.
2013
;
120
(
1
):
233
52
.
36.
Morris
R
.
Developments of a water-maze procedure for studying spatial learning in the rat
.
J Neurosci Methods
.
1984
;
11
(
1
):
47
60
.
37.
Dubey
H
,
Dubey
A
,
Gulati
K
,
Ray
A
.
Protective effects of L-arginine on cognitive deficits and biochemical parameters in an experimental model of type-2 diabetes mellitus induced Alzheimer’s disease in rats
.
J Physiol Pharmacol
.
2022
;
73
(
1
):
3
17
.
38.
Qosa
H
,
Mohamed
LA
,
Batarseh
YS
,
Alqahtani
S
,
Ibrahim
B
,
LeVine
H
3rd
, et al
.
Extra-virgin olive oil attenuates amyloid-β and tau pathologies in the brains of TgSwDI mice
.
J Nutr Biochem
.
2015
;
26
(
12
):
1479
90
. H.
39.
Park
SA
,
Chevallier
N
,
Tejwani
K
,
Hung
MM
,
Maruyama
H
,
Golde
TE
, et al
.
Deficiency in either COX-1 or COX-2 genes does not affect amyloid beta protein burden in amyloid precursor protein transgenic mice
.
Biochem Biophys Res Commun
.
2016
;
478
(
1
):
286
92
.
40.
Dubey
H
,
Dubey
A
,
Gulati
K
,
Ray
A
.
S-nitrosoglutathione modulates HDAC2 and BDNF levels in the brain and improves cognitive deficits in experimental model of Alzheimer’s disease in rats
;
2022
.
41.
Malinski
T
.
Nitric oxide and nitroxidative stress in Alzheimer’s disease
.
J Alzheimers Dis
.
2007
;
11
(
2
):
207
18
.
42.
Dubey
H
,
Gulati
K
,
Ray
A
.
Alzheimer’s disease: a contextual link with nitric oxide synthase
.
Curr Mol Med
.
2020
;
20
(
7
):
505
15
.
43.
Tropea
MR
,
Gulisano
W
,
Vacanti
V
,
Arancio
O
,
Puzzo
D
,
Palmeri
A
.
Nitric oxide/cGMP/CREB pathway and amyloid-beta crosstalk: from physiology to Alzheimer’s disease
.
Free Radic Biol Med
.
2022
;
193
(
Pt 2
):
657
68
.
44.
Ozkay
UD
,
Can
ÖD
,
Ozkay
Y
,
Oztürk
Y
.
Effect of benzothiazole/piperazine derivatives on intracerebroventricular streptozotocin-induced cognitive deficits
.
Pharmacol Rep
.
2012
;
64
(
4
):
834
47
.
45.
Ishrat
T
,
Khan
MB
,
Hoda
MN
,
Yousuf
S
,
Ahmad
M
,
Ansari
MA
, et al
.
Coenzyme Q10 modulates cognitive impairment against intracerebroventricular injection of streptozotocin in rats
.
Behav Brain Res
.
2006
;
171
(
1
):
9
16
.
46.
Agrawal
R
,
Mishra
B
,
Tyagi
E
,
Nath
C
,
Shukla
R
.
Effect of curcumin on brain insulin receptors and memory functions in STZ (ICV) induced dementia model of rat
.
Pharmacol Res
.
2010
;
61
(
3
):
247
52
.
47.
Tota
S
,
Kamat
PK
,
Saxena
G
,
Hanif
K
,
Najmi
AK
,
Nath
C
.
Central angiotensin converting enzyme facilitates memory impairment in intracerebroventricular streptozotocin treated rats
.
Behav Brain Res
.
2012
;
226
(
1
):
317
30
.
48.
Rajasekar
N
,
Dwivedi
S
,
Nath
C
,
Hanif
K
,
Shukla
R
.
Protection of streptozotocin induced insulin receptor dysfunction, neuroinflammation and amyloidogenesis in astrocytes by insulin
.
Neuropharmacology
.
2014
;
86
:
337
52
.
49.
Giasson
BI
,
Ischiropoulos
H
,
Lee
VMY
,
Trojanowski
JQ
.
The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer’s and Parkinson’s diseases
.
Free Radic Biol Med
.
2002
;
32
(
12
):
1264
75
.
50.
Ju
TC
,
Chen
S
,
Liu
CC
,
Yang
DI
.
Protective effects of S-nitrosoglutathione against amyloid beta-peptide neurotoxicity
.
Free Radic Biol Med
.
2005
;
38
(
7
):
938
49
.
51.
Javed
H
,
Khan
MM
,
Khan
A
,
Vaibhav
K
,
Ahmad
A
,
Khuwaja
G
, et al
.
S-allyl cysteine attenuates oxidative stress associated cognitive impairment and neurodegeneration in mouse model of streptozotocin-induced experimental dementia of Alzheimer’s type
.
Brain Res
.
2011
;
1389
:
133
42
.
52.
Bliss
TVP
,
Collingridge
GL
.
A synaptic model of memory: long-term potentiation in the hippocampus
.
Nature
.
1993
;
361
(
6407
):
31
9
.
53.
Takeuchi
T
,
Duszkiewicz
AJ
,
Morris
RGM
.
The synaptic plasticity and memory hypothesis: encoding, storage and persistence
.
Philos Trans R Soc Lond B Biol Sci
.
2014
;
369
(
1633
):
20130288
.
54.
Ying
SW
,
Futter
M
,
Rosenblum
K
,
Webber
MJ
,
Hunt
SP
,
Bliss
TVP
, et al
.
Brain-derived neurotrophic factor induces long-term potentiation in intact adult hippocampus: requirement for ERK activation coupled to CREB and upregulation of Arc synthesis
.
J Neurosci
.
2002
;
22
(
5
):
1532
40
.
55.
Manabe
T
.
Neurobiology: does BDNF have pre- or postsynaptic targets
.
Science
.
2002
;
2002
;
1651
1653
.
56.
Wiltgen
BJ
,
Brown
RAM
,
Talton
LE
,
Silva
AJ
.
New circuits for old memories: the role of the neocortex in consolidation
.
Neuron
.
2004
;
44
(
1
):
101
8
.
57.
Yavas
E
,
Gonzalez
S
,
Fanselow
MS
.
Interactions between the hippocampus, prefrontal cortex, and amygdala support complex learning and memory [version 1; peer review: 3 approved]
.
F1000Res
.
2019
;
8
:
F1000 Faculty Rev-1292
.
58.
Kim
JJ
,
Fanselow
MS
.
Modality-specific retrograde amnesia of fear
.
Science
.
1992
;
256
(
5057
):
675
7
.
59.
D’Hooge
R
,
De Deyn
PP
.
Applications of the Morris water maze in the study of learning and memory
.
Brain Res Rev
.
2001
;
36
(
1
):
60
90
.
60.
Lombroso
PJ
,
Ogren
MP
.
Learning and memory, Part I: brain regions involved in two types of learning and memory
.
J Am Acad Child Adolesc Psychiatry
.
2008
;
47
(
11
):
1228
32
.
61.
Cheignon
C
,
Tomas
M
,
Bonnefont-Rousselot
D
,
Faller
P
,
Hureau
C
,
Collin
F
.
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
.
Redox Biol
.
2018
;
14
:
450
64
.
62.
Tamagno
E
,
Guglielmotto
M
,
Vasciaveo
V
,
Tabaton
M
.
Oxidative stress and beta amyloid in alzheimer’s disease. Which comes first: the chicken or the egg
.
Antioxidants
.
2021
;
10
(
9
):
1479
.
63.
Nazem
A
,
Sankowski
R
,
Bacher
M
,
Al-Abed
Y
.
Rodent models of neuroinflammation for Alzheimer’s disease
.
J Neuroinflammation
.
2015
;
12
(
1
):
74
.
64.
Grieb
P
.
Intracerebroventricular streptozotocin injections as a model of Alzheimer???s disease: in search of a relevant mechanism
.
Mol Neurobiol
.
2016
;
53
(
3
):
1741
52
.
65.
Rauhala
P
,
Lin
M
,
Chiueh
CC
.
Neuroprotection by S-nitrosoglutathione of brain dopamine neurons from oxidative stress
.
FASEB J
.
1998
;
12
(
2
):
165
73
.
66.
Jiao
SS
,
Shen
LL
,
Zhu
C
,
Bu
XL
,
Liu
YH
,
Liu
CH
, et al
.
Brain-derived neurotrophic factor protects against tau-related neurodegeneration of Alzheimer’s disease
.
Transl Psychiatry
.
2016
;
6
(
10
):
e907
.
67.
Sutherland
RD
,
Martinez
HE
,
Guynes
WA
,
Miller
L
.
Postoperative chest wound infections in patients requiring coronary bypass
.
J Thorac Cardiovasc Surg
.
1977
;
73
(
6
):
944
7
.
68.
Tiwari
V
,
Mishra
A
,
Singh
S
,
Mishra
SK
,
Sahu
KK
,
Parul
, et al
.
Protriptyline improves spatial memory and reduces oxidative damage by regulating NFκB-BDNF/CREB signaling axis in streptozotocin-induced rat model of Alzheimer’s disease
.
Brain Res
.
2021
;
1754
:
147261
.
69.
Valvassori
SS
,
Arent
CO
,
Steckert
AV
,
Varela
RB
,
Jornada
LK
,
Tonin
PT
, et al
.
Intracerebral administration of BDNF protects rat brain against oxidative stress induced by ouabain in an animal model of mania
.
Mol Neurobiol
.
2015
;
52
(
1
):
353
62
.
70.
Airaki
M
,
Sánchez-Moreno
L
,
Leterrier
M
,
Barroso
JB
,
Palma
JM
,
Corpas
FJ
.
Detection and quantification of S-nitrosoglutathione (GSNO) in pepper (Capsicum annuum L.) plant organs by LC-ES/MS
.
Plant Cell Physiol
.
2011
;
52
(
11
):
2006
15
.
71.
Khan
M
,
Shunmugavel
A
,
Dhammu
TS
,
Khan
H
,
Singh
I
,
Singh
AK
.
Combined treatment with GSNO and CAPE accelerates functional recovery via additive antioxidant activities in a mouse model of TBI
.
J Neurosci Res
.
2018
;
96
(
12
):
1900
13
.
72.
He
T
,
Katusic
ZS
.
Brain-derived neurotrophic factor increases expression of MnSOD in human circulating angiogenic cells
.
Microvasc Res
.
2012
;
83
(
3
):
366
71
.
73.
Cheng
A
,
Wang
S
,
Cai
J
,
Rao
MS
,
Mattson
MP
.
Nitric oxide acts in a positive feedback loop with BDNF to regulate neural progenitor cell proliferation and differentiation in the mammalian brain
.
Dev Biol
.
2003
;
258
(
2
):
319
33
.
74.
Chen
MJ
,
Ivy
AS
,
Russo-Neustadt
AA
.
Nitric oxide synthesis is required for exercise-induced increases in hippocampal BDNF and phosphatidylinositol 3′ kinase expression
.
Brain Res Bull
.
2006
;
68
(
4
):
257
68
.
75.
Butterfield
DA
,
Swomley
AM
,
Sultana
R
.
Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression
.
Antioxid Redox Signal
.
2013
;
19
(
8
):
823
35
.
76.
Wruck
CJ
,
Götz
ME
,
Herdegen
T
,
Varoga
D
,
Brandenburg
LO
,
Pufe
T
.
Kavalactones protect neural cells against amyloid beta peptide-induced neurotoxicity via extracellular signal-regulated kinase 1/2-dependent nuclear factor erythroid 2-related factor 2 activation
.
Mol Pharmacol
.
2008
;
73
(
6
):
1785
95
.
77.
Dhakshinamoorthy
S
,
Porter
AG
.
Nitric oxide-induced transcriptional up-regulation of protective genes by Nrf2 via the antioxidant response element counteracts apoptosis of neuroblastoma cells
.
J Biol Chem
.
2004
;
279
(
19
):
20096
107
.
78.
Mitre
M
,
Mariga
A
,
Chao
MV
.
Neurotrophin signalling: novel insights into mechanisms and pathophysiology
.
Clin Sci
.
2017
;
131
(
1
):
13
23
.
79.
Gupta
VK
,
You
Y
,
Gupta
VB
,
Klistorner
A
,
Graham
SL
.
TrkB receptor signalling: implications in neurodegenerative, psychiatric and proliferative disorders
.
Int J Mol Sci
.
2013
;
14
(
5
):
10122
42
.
80.
Bouvier
E
,
Brouillard
F
,
Molet
J
,
Claverie
D
,
Cabungcal
JH
,
Cresto
N
, et al
.
Nrf2-dependent persistent oxidative stress results in stress-induced vulnerability to depression
.
Mol Psychiatry
.
2017
;
22
(
12
):
1701
13
.
81.
Yao
W
,
Lin
S
,
Su
J
,
Cao
Q
,
Chen
Y
,
Chen
J
, et al
.
Activation of BDNF by transcription factor Nrf2 contributes to antidepressant-like actions in rodents
.
Transl Psychiatry
.
2021
;
11
(
1
):
140
.
82.
Balez
R
,
Ooi
L
.
Getting to NO Alzheimer’s disease: neuroprotection versus neurotoxicity mediated by nitric oxide
.
Oxid Med Cell Longev
.
2016
;
2016
:
3806157
.
You do not currently have access to this content.